High Levels of Class I Major Histocompatibility Complex mRNA Are Present in Epstein-Barr Virus-Associated Gastric

Farhad Ghasemi1, Steven F Gameiro2, Tanner M Tessier2

  • 1Department of Surgery, Western University, London, ON N6A 3K7, Canada.

Cells
|February 27, 2020
PubMed

Insights

Epstein-Barr virus (EBV) does not reduce major histocompatibility complex I (MHC-I) in most stomach cancers. Instead, EBV-associated gastric cancers show higher MHC-I mRNA levels, suggesting a different immune response mechanism.

Area of Science:

  • Oncology
  • Virology
  • Immunology

Background:

  • Epstein-Barr virus (EBV) is linked to 9% of stomach adenocarcinomas.
  • EBV microRNAs were previously thought to evade immune responses by reducing MHC-I antigen presentation.
  • This study investigates EBV's effect on the MHC-I pathway in gastric cancer.

Purpose of the Study:

  • To assess the impact of EBV on MHC-I heavy and light chain mRNA levels in human gastric carcinomas.
  • To investigate the relationship between EBV, MHC-I expression, and immune cell infiltration in gastric cancer.

Main Methods:

  • Analysis of mRNA levels for MHC-I components and antigen processing/presentation factors.
  • Utilized data from nearly 400 human gastric carcinomas (GCs).
  • Correlated gene expression with intratumoral interferon-gamma levels and immune cell infiltration.

Main Results:

  • Contrary to expectations, MHC-I mRNA levels were not reduced in EBV-associated gastric carcinomas (EBVaGCs).
  • MHC-I and related gene mRNA levels were as high or higher in EBVaGCs compared to normal tissues and other GC subtypes.
  • Upregulation correlated with increased interferon-gamma and T/NK cell infiltration in EBVaGCs.

Conclusions:

  • EBV-encoded products do not effectively reduce MHC-I antigen presentation machinery mRNA levels in human gastric cancer.
  • EBVaGCs exhibit an upregulation of MHC-I pathway components, potentially driven by interferon-gamma.
  • This suggests a complex interplay between EBV and the host immune response in gastric carcinogenesis.

Related Concept Videos

Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
502
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
13.0K